Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;5(1):11-16.
doi: 10.1212/CPJ.0000000000000089.

Aspirin and intracerebral hemorrhage: Where are we now?

Affiliations

Aspirin and intracerebral hemorrhage: Where are we now?

Réza Behrouz et al. Neurol Clin Pract. 2015 Feb.

Abstract

For the past 3 decades, aspirin has been widely used for prevention of ischemic stroke and myocardial infarction. Although the evidence supporting the effectiveness of aspirin in prevention of vascular events is clear, data regarding the risk of acute and recurrent intracerebral hemorrhage related to the use of this medication have been conflicting. We review past and contemporary data on aspirin use in relation to intracerebral hemorrhage.

PubMed Disclaimer

References

    1. Sneader W. The discovery of aspirin: a reappraisal. BMJ. 2000;321:1591–1594. - PMC - PubMed
    1. Weiss HJ, Aledort LM. Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet. 1967;2:495–497. - PubMed
    1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy: I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81–106. - PMC - PubMed
    1. Albers GW. Antithrombotic agents in cerebral ischemia. Am J Cardiol. 1995;75:34B–38B. - PubMed
    1. Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003;110:255–258. - PubMed

LinkOut - more resources